
Alert: New Earnings Report (5/7/24)-Ligand Pharmaceuticals Inc (NASDAQ: LGND).
Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported earnings for its first fiscal quarter (ending March 31) of $4.86 versus $2.56 for the same period a year ago — an increase of 90%. This performance was […]